Abstract
ObjectivesTo evaluate the long-term safety and efficacy of belimumab in patients with systemic lupus erythematosus (SLE) in China.MethodsIn this phase 3, open-label extension period, eligible completers of study BEL113750 (NCT01345253)...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have